ResearchUNC Charlotte

Charlotte Scientists Lead Research On Effective COVID Boosting

For many, the threat of the COVID-19 pandemic seems over. However, for patients whose immune systems are compromised by cancer or by cancer therapies, fear of COVID-19 infection and severe disease remains very real.

Currently, CDC guidance recommends that immunocompromised patients receive COVID-19 booster shots “as needed.” While this flexibility is useful for patients with complex medical conditions, more specific guidance is lacking as to when additional COVID-19 boosting would be most effective. 

New research led by scientists the University of North Carolina at Charlotte and Yale University provides this critically needed information. The rate at which additional COVID-19 boosters are needed for cancer patients, the researchers say, depends on the treatment they are receiving.

MORE >>>